Literature DB >> 14707080

CD23 trimers are preassociated on the cell surface even in the absence of its ligand, IgE.

Michelle A Kilmon1, Anne E Shelburne, Yee Chan-Li, Kevin L Holmes, Daniel H Conrad.   

Abstract

Allergic disease is mediated by high levels of allergen-specific IgE. IgE binding to CD23, the low affinity receptor for IgE, results in a negative feedback signal leading to a decrease in IgE production. Previous studies have shown that CD23 associates as an oligomer and that cooperative binding of at least two lectin domains is required for high affinity IgE binding to CD23. We have previously shown that cooperative binding is required for regulation of IgE production. This study describes the production of several mAbs that bind the stalk region of murine CD23. One of the Abs, 19G5, inhibited the IgE/CD23 interaction at 37 degrees C, but not at 4 degrees C. Analysis of the binding properties of these Abs revealed that CD23 dissociates at high temperatures, such as 37 degrees C; however, the N terminus is constitutively associated, indicating partial, rather than complete, dissociation. A novel finding was that the stalk region, previously thought to mediate trimer association, was not required for oligomerization. These data reveal important information about the structure of CD23 that may be useful in modulating IgE production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707080     DOI: 10.4049/jimmunol.172.2.1065

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  CD23/FcεRII: molecular multi-tasking.

Authors:  M Acharya; G Borland; A L Edkins; L M Maclellan; J Matheson; B W Ozanne; W Cushley
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

2.  CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes.

Authors:  Joel A Mathews; David R Gibb; Bing-Hung Chen; Peggy Scherle; Daniel H Conrad
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

3.  Hyper IgE in New Zealand black mice due to a dominant-negative CD23 mutation.

Authors:  Graham Lewis; Eleni Rapsomaniki; Tiphaine Bouriez; Tanya Crockford; Helen Ferry; Robert Rigby; Timothy Vyse; Teresa Lambe; Richard Cornall
Journal:  Immunogenetics       Date:  2004-10-19       Impact factor: 2.846

4.  Development of expressed sequence tags from the bay scallop, Argopecten irradians irradians.

Authors:  Linsheng Song; Wei Xu; Chenhua Li; Honglei Li; Longtao Wu; Jianhai Xiang; Ximing Guo
Journal:  Mar Biotechnol (NY)       Date:  2006-03-16       Impact factor: 3.619

Review 5.  Fc receptors as adaptive immunoreceptors.

Authors:  Marc Daëron
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 6.  Soluble IgE receptors--elements of the IgE network.

Authors:  Barbara Platzer; Floortje Ruiter; John van der Mee; Edda Fiebiger
Journal:  Immunol Lett       Date:  2011-09-06       Impact factor: 3.685

7.  A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma.

Authors:  J A Mathews; J Ford; S Norton; D Kang; A Dellinger; D R Gibb; A Q Ford; H Massay; C L Kepley; P Scherle; A D Keegan; D H Conrad
Journal:  Allergy       Date:  2011-05-10       Impact factor: 13.146

8.  129/SvJ mice have mutated CD23 and hyper IgE.

Authors:  Jill W Ford; Jamie L Sturgill; Daniel H Conrad
Journal:  Cell Immunol       Date:  2008-10-01       Impact factor: 4.868

9.  ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo.

Authors:  David R Gibb; Mohey El Shikh; Dae-Joong Kang; Warren J Rowe; Rania El Sayed; Joanna Cichy; Hideo Yagita; John G Tew; Peter J Dempsey; Howard C Crawford; Daniel H Conrad
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

10.  Adrenergic regulation of IgE involves modulation of CD23 and ADAM10 expression on exosomes.

Authors:  Caroline J Padro; Todd M Shawler; Matthew G Gormley; Virginia M Sanders
Journal:  J Immunol       Date:  2013-10-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.